| HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors SA Migueles, AC Laborico, WL Shupert, MS Sabbaghian, R Rabin, ... Nature immunology 3 (11), 1061-1068, 2002 | 1240 | 2002 |
| Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity R Vogels, D Zuijdgeest, R van Rijnsoever, E Hartkoorn, I Damen, ... Journal of virology 77 (15), 8263-8271, 2003 | 565 | 2003 |
| Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity DH Barouch, MG Pau, JHHV Custers, W Koudstaal, S Kostense, ... The Journal of Immunology 172 (10), 6290-6297, 2004 | 456 | 2004 |
| Persistent numbers of tetramer+ CD8+ T cells, but loss of interferon-γ+ HIV-specific T cells during progression to AIDS S Kostense, K Vandenberghe, J Joling, D Van Baarle, N Nanlohy, ... Blood, The Journal of the American Society of Hematology 99 (7), 2505-2511, 2002 | 243 | 2002 |
| High viral burden in the presence of major HIV‐specific CD8+ T cell expansions: evidence for impaired CTL effector function S Kostense, GS Ogg, EH Manting, G Gillespie, J Joling, K Vandenberghe, ... European journal of immunology 31 (3), 677-686, 2001 | 243 | 2001 |
| Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study F de Wolf, M Ghanbari, S Licher, K McRae-McKee, L Gras, GJ Weverling, ... Brain 143 (4), 1220-1232, 2020 | 231 | 2020 |
| Evidence that human CD8+CD45RA+CD27– cells are induced by antigen and evolve through extensive rounds of division D Hamann, S Kostense, KC Wolthers, SA Otto, PA Baars, F Miedema, ... International Immunology 11 (7), 1027-1033, 1999 | 228 | 1999 |
| Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors MC Sprangers, W Lakhai, W Koudstaal, M Verhoeven, BF Koel, R Vogels, ... Journal of clinical microbiology 41 (11), 5046-5052, 2003 | 212 | 2003 |
| Dysfunctional Epstein-Barr virus (EBV)–specific CD8+T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non … D van Baarle, E Hovenkamp, MFC Callan, KC Wolthers, S Kostense, ... Blood, The Journal of the American Society of Hematology 98 (1), 146-155, 2001 | 210 | 2001 |
| Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors SM Sumida, DM Truitt, MG Kishko, JC Arthur, SS Jackson, DA Gorgone, ... Journal of virology 78 (6), 2666-2673, 2004 | 207 | 2004 |
| Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector S Kostense, W Koudstaal, M Sprangers, GJ Weverling, G Penders, ... Aids 18 (8), 1213-1216, 2004 | 202 | 2004 |
| Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression GS Ogg, S Kostense, MR Klein, S Jurriaans, D Hamann, AJ McMichael, ... Journal of virology 73 (11), 9153-9160, 1999 | 197 | 1999 |
| Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue D van Baarle, S Kostense, MHJ van Oers, D Hamann, F Miedema Trends in immunology 23 (12), 586-591, 2002 | 163 | 2002 |
| First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity ABH Bakker, C Python, CJ Kissling, P Pandya, WE Marissen, MF Brink, ... Vaccine 26 (47), 5922-5927, 2008 | 162 | 2008 |
| Lack of Epstein-Barr virus-and HIV-specific CD27− CD8+ T cells is associated with progression to viral disease in HIV-infection D van Baarle, S Kostense, E Hovenkamp, G Ogg, N Nanlohy, MFC Callan, ... Aids 16 (15), 2001-2011, 2002 | 100 | 2002 |
| An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity OJAE Ophorst, S Kostense, J Goudsmit, RL De Swart, S Verhaagh, ... Vaccine 22 (23-24), 3035-3044, 2004 | 93 | 2004 |
| Intraspecies variation in lethal body burdens of narcotic compounds AP van Wezef, DAM de Vries, S Kostense, DTHM Sijm, A Opperhuizen Aquatic toxicology 33 (3-4), 325-342, 1995 | 86 | 1995 |
| Preclinical models used for immunogenicity prediction of therapeutic proteins V Brinks, D Weinbuch, M Baker, Y Dean, P Stas, S Kostense, B Rup, ... Pharmaceutical research 30, 1719-1728, 2013 | 72 | 2013 |
| Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy S Kostense, FM Raaphorst, DW Notermans, J Joling, B Hooibrink, ... Aids 12 (18), F235-F240, 1998 | 60 | 1998 |
| Functional restoration of human immunodeficiency virus and Epstein‐Barr virus‐specific CD8+ T cells during highly active antiretroviral therapy is associated with an increase … S Kostense, SA Otto, GJ Knol, EH Manting, NM Nanlohy, C Jansen, ... European journal of immunology 32 (4), 1080-1089, 2002 | 54 | 2002 |
